Results revealed that non-canonical Wnt5a signaling and JNK activity correlated with vascular reluctance to insulin action and to induce endothelial dysfunction, thus offering a novel therapeutic opportunity to protect the vasculature in patients with diabetes mellitus [57]. The gene discussed is MAPK8; the disease is diabetes mellitus.